aktie
It is not yet clear what development the vaccine specialist Biontech will take after the departure of its founders. At least it is now clear who will succeed Uğur Şahin in the executive chair.
Peak volume
200+
First seen
2026-08-03
Last seen
2026-08-03
Days trending
1 / 1
Countries
3
Trending timeline
Latest related news (2026-08-03)
-
-
-
BioNTech: Nachfolger für Sahin gefunden - Aktie legt zu — finanzen.ch